• Profile
Close

Paip1 predicts poor prognosis and promotes tumor progression through AKT/GSK-3β pathway in lung adenocarcinoma

Human Pathology Mar 29, 2019

Wang Y, et al. - Since the expression and biological role of Paip1 in most human cancers is not well understood, researchers studied its clinical value and role in lung adenocarcinoma (LADC). In 58 LADC patients with strict follow-up and 60 cases of adjacent normal lung tissues, they used immunohistochemistry to determine Paip1 expression. According to findings, in LADC, Paip1 expression is significantly upregulated and its overexpression is related to poor prognosis in these patients. Attenuated Paip1 expression, by regulating the signaling pathway of AKT/GSK-3β, suppresses proliferation and epithelial-to-mesenchymal transition-related migration of A549 and H1299 cells.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay